| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2024 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Buy | 25,000 | $6.05 | $151,327.50 | +2.2% | +6.6% | -2.4% | |
| May 31, 2024 | CATX Perspective Therapeutics, Inc. | Williamson Robert F III63 | Director | Buy | 55,000 | $1.38 | $75,900.00 | +14.9% | +12.9% | -81.4% | |
| May 31, 2024 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 1,000 | $1.96 | $1,957.50 | - | +18.7% | +10.4% | |
| May 30, 2024 | TNDM Tandem Diabetes Care Inc | Allen Dick69 | Director | Sell | 5,000 | $51.68 | $258,400.00 | -100% | -16.9% | -62.9% | |
| May 30, 2024 | RCEL Avita Medical, Inc. | O'Toole David D47 | CFO | Buy | 1,000 | $8.90 | $8,900.00 | +2.6% | -2.0% | -39.6% | |
| May 30, 2024 | GKOS Glaukos Corp | Kliman Gilbert H64 | Director | Sell | 5,000 | $112.00 | $560,000.00 | -14.0% | +22.3% | -14.8% | |
| May 30, 2024 | ICUI Icu Medical Inc/de | Voigtlander Christian B.64 | Chief Operating Officer | Sell | 12,539 | $103.95 | $1,303,484.51 | -86.1% | +57.5% | +30.3% | |
| May 30, 2024 | EW Edwards Lifesciences Corp | Zovighian Bernard J55 | CEO | Sell | 8,617 | $87.68 | $755,538.56 | -11.2% | -21.9% | -11.0% | |
| May 30, 2024 | ATRC Atricure, Inc. | Privitera Salvatore74 | Chief Technical Officer | Buy | 5,000 | $22.25 | $111,250.00 | +5.1% | +15.0% | +55.3% | |
| May 30, 2024 | NEPH Nephros Inc | Amron Arthur H45 | Director | Buy | 5,000 | $2.24 | $11,176.10 | +2.5% | -15.7% | +23.6% | |
| May 29, 2024 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality And Operations | Sell | 408 | $21.78 | $8,886.24 | -0.3% | +19.7% | +3.4% | |
| May 29, 2024 | TMCI Treace Medical Concepts, Inc. | Treace James T53 | Director | Buy | 25,000 | $5.20 | $130,062.50 | +2.3% | +16.3% | +11.0% | |
| May 29, 2024 | CATX Perspective Therapeutics, Inc. | Williamson Robert F III63 | Director | Buy | 30,031 | $1.33 | $40,014.04 | +4.4% | +13.3% | -80.0% | |
| May 29, 2024 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 574 | $21.78 | $12,501.72 | -0.5% | +19.7% | +3.4% | |
| May 29, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 14,282 | $0.93 | $13,319.39 | - | +2.7% | -26.5% | |
| May 29, 2024 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 345 | $21.78 | $7,514.10 | -0.5% | +19.7% | +3.4% | |
| May 29, 2024 | BSX Boston Scientific Corp | Mirviss Jeffrey B.45 | EVP&Pres, Periph Intervent | Sell | 63,802 | $75.10 | $4,791,447.26 | -69.5% | +6.5% | +39.4% | |
| May 29, 2024 | MYO Myomo, Inc. | Kirk Thomas F55 | Director | Buy | 50,000 | $3.50 | $175,000.00 | +26.8% | +13.8% | -14.9% | |
| May 29, 2024 | TMDX Transmedics Group, Inc. | Weill David63 | Director | Sell | 1,193 | $141.65 | $168,988.45 | -10.0% | +23.8% | -10.3% | |
| May 29, 2024 | TMDX Transmedics Group, Inc. | Gordon Stephen52 | Chief Financial Officer | Sell | 20,000 | $141.40 | $2,828,024.70 | -21.6% | +23.8% | -10.3% | |
| May 29, 2024 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 345 | $21.78 | $7,514.10 | -0.3% | +19.7% | +3.4% | |
| May 29, 2024 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 517 | $21.78 | $11,260.26 | -0.2% | +19.7% | +3.4% | |
| May 29, 2024 | HAE Haemonetics Corp | Basil Michelle L51 | EVP And General Counsel | Sell | 12,990 | $88.08 | $1,144,208.14 | -16.3% | -12.3% | -22.5% | |
| May 29, 2024 | ARAY Accuray Inc | Whitters Joseph E | Director | Buy | 100,000 | $1.56 | $156,045.00 | +10.3% | +48.1% | 0.0% | |
| May 29, 2024 | HAE Haemonetics Corp | Strong Stewart W67 | President, Global Hospital | Sell | 8,857 | $87.53 | $775,253.21 | -32.7% | -12.3% | -22.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.